John Saharek P.'s most recent trade in Harrow Health Inc was a trade of 277,200 Performance Stock Unit done . Disclosure was reported to the exchange on April 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Harrow Health Inc | John Saharek P. | CEO & President, ImprimisRx | 03 Apr 2025 | 277,200 | 0 | - | - | Performance Stock Unit | ||
| Harrow Health Inc | John Saharek P. | CEO & President, ImprimisRx | 03 Apr 2025 | 277,200 | 576,863 (2%) | 1% | 0 | Common Stock | ||
| Harrow Health Inc | John Saharek P. | CEO & President, ImprimisRx | 03 Apr 2025 | 109,475 | 467,388 (1%) | 0% | 23.1 | 2,527,778 | Common Stock |